Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
International Clinical Psychopharmacology|October 27, 2011
Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studiesRichard H Weisler, Stuart A Montgomery, Willie R Earley, et al.The Journal of Clinical Psychiatry|February 10, 2010
Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorderLenard A Adler, Richard H Weisler, David W Goodman, et al.Psychiatry (Edgmont (Pa. : Township))|September 4, 2009
Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorderRichard H Weisler, Amir H Kalali, Andrew J Cutler, et al.CNS Spectrums|September 30, 2006
The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trialsRichard H Weisler, Andrew J Cutler, James C Ballenger, et al.Clinical Therapeutics|May 9, 2006
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group studyThomas J Spencer, Timothy E Wilens, Joseph Biederman, et al.CNS Drugs|July 17, 2017
Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical StudyRichard H Weisler, Michael Greenbaum, Valerie Arnold, et al.Journal of Clinical Psychopharmacology|November 18, 2006
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)Michael E Thase, Wayne Macfadden, Richard H Weisler, et al.The Journal of Clinical Psychiatry|May 3, 2008
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studiesRichard H Weisler, Joseph R Calabrese, Michael E Thase, et al.Journal of Affective Disorders|June 21, 2016
Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environmentRichard H Weisler, Ai Ota, Kana Tsuneyoshi, et al.Journal of Affective Disorders|November 16, 2007
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistenceRichard H Weisler, Joseph R Calabrese, Charles L Bowden, et al.Pageof 6